Health Condition 1: T799- Unspecified early complication oftrauma Health Condition 2: T14- Injury of unspecified body region Health Condition 3: T794- Traumatic shock
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: -112/108 calls routed to the ambulance dispatch centre(Call center) from within the cluster boundaries during the study period. -Dispatcher classification as trauma with external haemorrhage or amputation/major limb trauma. -Scene accessible for drone overhead delivery (open rooftop/roadside/field).
Exclusion criteria
Exclusion criteria: Airspace/operational no-go (severe weather, a notice to airmen (NOTAM), VIP movement), unsafe crowds, or lack of GPS lock. Indoor entrapment without line of sight; high-rise window only access. Mass-casualty incidents (handled under separate protocols). Interfacility transfers
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time to first effective haemorrhage control :Time (in minutes) from 112/108 call receipt (T0) to the first documented application of a tourniquet, pressure bandage, or haemostatic gauze to a bleeding wound at the sceneTimepoint: Baseline | — |
Secondary
| Measure | Time frame |
|---|---|
| Eligibility and Coverage: Number and proportion of eligible calls identified per cluster-period; proportion of eligible calls where UAV dispatch was attempted as per protocolTimepoint: 0 minutes;Operational Performance (Drone Dispatch Success): Proportion of episodes with successful dispatch, launch within 5 minutes, and successful kit delivery to sceneTimepoint: 5 minutes;Data Completeness: Proportion of study episodes with complete primary outcome timestamp data specifically, both call receipt time (T0) and time of first effective haemorrhage control along with other key operational timestamps (dispatch time, launch time, kit delivery time), captured across EMS logs, UAV logs, and dispatcher logsTimepoint: Assessed per episode, reported cumulatively at the end of each cluster-period and at the end of the overall study period;Safety : Number and nature of drone-related and kit-related adverse eventsTimepoint: Continuously monitored and reported per episode throughout the study | — |
Countries
India
Contacts
Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER)